Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.
In a recent move by Clarity Pharmaceuticals Ltd., Director Rosanne Elizabeth Robinson exercised 200,000 options, converting them into 178,079 fully paid ordinary shares, with the options valued at $165,000. This transaction was executed on a cashless basis using a 5-day Volume Weighted Average Price (VWAP) of $7.5272 prior to the exercise instruction. After the change, Robinson’s direct holdings in the company now consist of 178,079 ordinary shares.
For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.